SCHEMBL23957670

SCHEMBL23957670

CN(C(=O)c1ccc(N2CCCC2)nc1)c1ccc(B2OC(C)(C)C(C)(C)O2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
ALOX15 P16050 1/20 0.39
UBE2T Q9NPD8 1/20 0.39
MCHR1 Q99705 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
SLC6A9 P48067 1/20 0.35
SLC6A5 Q9Y345 1/20 0.35
MLNR O43193 1/20 0.35
DGAT1 O75907 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484906 0.81 MAPT (0.44) ALDH1A1UBE2TSMN1; SMN2NPSR1DGAT1
SCHEMBL29378036 0.81 MAPT (0.44) ALDH1A1UBE2TSMN1; SMN2NPSR1DGAT1
SCHEMBL1330752 0.80 MAPT (0.46) ALDH1A1UBE2TSMN1; SMN2NPSR1DGAT1
SCHEMBL29377874 0.80 MAPT (0.46) ALDH1A1UBE2TSMN1; SMN2NPSR1DGAT1
SCHEMBL2068884 0.79 MAPT (0.41) ALDH1A1HPGDHSD17B10KDM4EUBE2T
SCHEMBL23929986 0.79 UBE2T (0.45) ALDH1A1HPGDHSD17B10KDM4EPOLB
SCHEMBL23929961 0.77 SMN1; SMN2 (0.33) ALDH1A1HSD17B10SMN1; SMN2NPSR1
SCHEMBL23929958 0.77 SMN1; SMN2 (0.33) ALDH1A1HSD17B10SMN1; SMN2NPSR1
SCHEMBL30257772 0.77 SMN1; SMN2 (0.33) ALDH1A1HSD17B10SMN1; SMN2NPSR1
SCHEMBL31646023 0.76 KDM4E (0.40) ALDH1A1HPGDHSD17B10KDM4EHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605477-B Pyrazolo [1,5-a ] pyridine derivative, preparation method, composition and application thereof 深圳众格生物科技有限公司 2024-07-05 CN disclosed
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 US disclosed
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 US disclosed
EP-4141003-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF Shenzhen Zhongge Biological Technology Co., Ltd. (CN) 2023-03-01 EP disclosed
CN-115605477-A Pyrazolo [1,5-a ] pyridine derivative and preparation method, composition and application thereof 深圳众格生物科技有限公司(CN) 2023-01-13 CN disclosed
WO-2021213476-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF 深圳晶泰科技有限公司 (CN) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF NCOA4, CCDC47, CCDC6 ALDH1A1 2273/4885HPGD 4452/4885HSD17B10 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.